Business Context and Reporting Period
Company: The Hain Celestial Group, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended December 31, 2002 (Fiscal Year 2003, Q2).
Business Overview: A leading manufacturer and marketer of natural, specialty, organic, and snack food products. The company operates in one segment, selling brands such as Celestial Seasonings, Hain Pure Foods, Westsoy, and Imagine Foods. Approximately 54% of revenues are derived from products manufactured in-house, with the remainder produced by co-packers.
Key Financial Metrics
Revenue and Profitability (Six Months Ended Dec 31, 2002):
- Net Sales: $219.4 million (Increase of 12.6% vs. prior year).
- Gross Profit: $69.6 million (Gross Margin: 31.7% vs. 30.3% prior year).
- Operating Income: $21.1 million (Operating Margin: 9.6% vs. 9.8% prior year).
- Net Income: $12.9 million (Diluted EPS: $0.37 vs. $0.31 prior year).
Liquidity and Balance Sheet (As of Dec 31, 2002):
- Cash and Cash Equivalents: $12.7 million.
- Working Capital: $83.3 million (Current Ratio: 2.3 to 1).
- Total Debt: $58.7 million (Comprising $3.1 million current and $55.6 million long-term).
- Debt Facility: $240 million total credit facility available; $48.7 million outstanding under the revolving portion.
Cash Flow (Six Months Ended Dec 31, 2002):
- Operating Cash Flow: $12.2 million provided.
- Investing Cash Flow: $48.9 million used (primarily due to the $44.7 million acquisition of Imagine Foods).
- Financing Cash Flow: $42.1 million provided (primarily $44.3 million borrowed to fund the Imagine acquisition).
Material Changes vs. Prior Period
- Revenue Growth: Driven by organic growth (approx. 9%) and acquisitions (approx. 8%), specifically the December 2002 acquisition of Imagine Foods and the December 2001 acquisition of Lima/Biomarche.
- Margin Expansion: Gross margin improved to 31.7% due to a favorable product mix and reduced distribution costs, partially offset by lower margins in European operations.
- Expense Increases: Selling, general, and administrative (SG&A) expenses rose to $48.1 million (21.9% of sales) due to increased consumer advertising ($5 million increase) and infrastructure costs related to new acquisitions.
- Restructuring Charges: Recorded $0.4 million in non-recurring charges related to the sale of the Health Valley facility. Total accrued restructuring liabilities stood at $5.4 million.
- Interest Expense: Significantly lower than the prior year ($0.4 million vs. $1.9 million) due to the absence of a $1.5 million loss incurred in the prior year from closing the Terra Chips facility in Brooklyn.
Guidance, Outlook, and Risks
Management Commentary: Management expects the effective tax rate to approximate 38% for the remainder of Fiscal 2003. The company anticipates completing the purchase price allocation for the Imagine Foods acquisition by the fourth quarter of Fiscal 2003, with most excess cost allocated to goodwill and trademarks.
Liquidity Outlook: Management believes cash on hand, projected operating cash flows, and the available credit facility are sufficient to fund working capital, anticipated capital expenditures ($6.0 million), restructuring costs ($5.4 million), and debt obligations for the remainder of the fiscal year.
Risks and Contingencies:
- Seasonality: Tea, soup, and hot cereal sales are seasonal, with higher demand in cooler months.
- Acquisition Integration: Risks associated with integrating new acquisitions (Imagine, Lima) and realizing projected synergies.
- Customer Concentration: Two customers represent approximately 30% of trade receivables, though management believes there is no current credit exposure.
- Forward-Looking Statements: Results may be materially affected by general economic conditions, competition, and regulatory changes.
Investor Verification Checklist
- Acquisition Impact: Verify the integration progress and financial contribution of the Imagine Foods acquisition (closed Dec 2, 2002) and Lima/Biomarche.
- Debt Utilization: Monitor the utilization of the $240 million credit facility, currently at $48.7 million, and compliance with covenants.
- Restructuring Costs: Track the remaining $5.4 million in accrued restructuring charges and the potential for additional charges related to the Health Valley facility sale.
- European Margins: Assess the impact of lower gross profits in European operations on overall margin trends.
- Seasonal Trends: Evaluate Q3 and Q4 performance relative to the seasonal demand for hot tea and soup products.